A recent meta-study has found that taking a median dose of 3,320 IU of vitamin D per day can result in various cardiometabolic benefits. The study analyzed data from 99 randomized, controlled trials involving 17,656 participants from around the world. The researchers found that this level of supplementation was associated with reductions in blood pressure, cholesterol levels, hemoglobin A1C, and fasting blood glucose and insulin.
One of the key findings of the meta-study was that vitamin D supplementation appeared to provide the most significant benefits to certain populations. Non-Westerners, individuals with lower levels of circulating vitamin D, those with a BMI under 30, and people ages 50 and older were found to benefit the most from supplementation. The researchers believe that these populations may need higher doses of vitamin D to achieve optimal cardiometabolic health outcomes.
While there is evidence linking vitamin D supplementation to a lower risk of heart disease, the medical community is still unsure about the direct cause and effect relationship. Low serum vitamin D levels have been associated with increased cardiovascular risk, but it is unclear whether this is a cause or consequence of heart disease. Further research is needed to establish definitive conclusions on the impact of vitamin D on cardiovascular health.
The meta-study also identified several sources of heterogeneity in previous studies that may have contributed to conflicting findings. Factors such as ethnocultural background, age, body weight, and initial levels of circulating vitamin D were found to influence the results of the studies. Researchers believe that personalized intervention strategies may be necessary to achieve optimal levels of vitamin D for cardiometabolic health based on individual characteristics.
The findings of the meta-study suggest that a one-size-fits-all approach to vitamin D supplementation may not be effective. Personalized intervention strategies that take into consideration a person’s ethnocultural background and biological features may be needed to achieve optimal cardiometabolic health outcomes. In particular, individuals with obesity and low vitamin D levels may require higher doses of supplementation for longer durations to see significant improvements in their health.
Overall, while the meta-study highlights the potential benefits of vitamin D supplementation for cardiometabolic health, further research is needed to fully understand its impact. By considering individual factors such as ethnocultural background, age, and initial vitamin D levels, healthcare providers can develop personalized intervention strategies to help individuals achieve optimal levels of vitamin D and improve their cardiometabolic health.
